2,3-dinor-thromboxane b2 has been researched along with linoleic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falardeau, P; Grose, JH; Hui, R; Lebel, M; Robillard, M | 1 |
| Blair, IA; Dougherty, RM; Iacono, JM; Phillips, MA; Prakash, C | 1 |
| Freese, R; Mutanen, M; Pajari, AM; Sauer, R; Turpeinen, AM | 1 |
1 trial(s) available for 2,3-dinor-thromboxane b2 and linoleic acid
| Article | Year |
|---|---|
Dietary modification of omega 6 fatty acid intake and its effect on urinary eicosanoid excretion.
Topics: 6-Ketoprostaglandin F1 alpha; Chromatography, Thin Layer; Dietary Fats; Dinoprostone; Eicosanoids; Energy Intake; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Female; Humans; Linoleic Acid; Linoleic Acids; Middle Aged; Thromboxane B2 | 1993 |
2 other study(ies) available for 2,3-dinor-thromboxane b2 and linoleic acid
| Article | Year |
|---|---|
Arachidonic acid does not share the antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids in a model of angiotensin II-induced hypertension in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acid; Fatty Acids, Omega-3; Hypertension; Indomethacin; Linoleic Acid; Linoleic Acids; Male; Rats; Rats, Inbred Strains; Thromboxane B2 | 1991 |
Replacement of dietary saturated by unsaturated fatty acids: effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man.
Topics: Adult; Blood Platelets; Dietary Fats, Unsaturated; Fatty Acids; Female; Humans; Linoleic Acid; Male; Oleic Acid; Platelet Aggregation; Protein Kinase C; Thromboxane B2 | 1998 |